國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Adenosine receptors and Parkinson's ...

Jenner, Peter, (1946-)

Adenosine receptors and Parkinson's disease

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Adenosine receptors and Parkinson's diseaseedited by Hiroshi Kase, Peter J. Richardson, Peter Jenner.
其他作者:	Kase, Hiroshi.
出版者:	San Diego, CA :Academic Press,c2000.
面頁冊數:	xviii, 275 p. [1] col. plate :ill. ;24 cm.
標題:	Parkinson's disease.
電子資源:	An electronic book accessible through the World Wide Web; click for information
ISBN:	9780124004054

Adenosine receptors and Parkinson's disease
Adenosine receptors and Parkinson's disease[electronic resource] /edited by Hiroshi Kase, Peter J. Richardson, Peter Jenner. - San Diego, CA :Academic Press,c2000. - xviii, 275 p. [1] col. plate :ill. ;24 cm. - Pure and applied mathematics series ;v. 90. - Pure and applied mathematics (Academic Press) ;140..

Includes bibliographical references and index.

H. Kase, Introductory Remarks: Adenosine A2A Receptor Antagonists: A Novel Approach to the Treatment of Parkinson's Disease. -- S.J. Augood, P.C. Emsom, and D.G. Standaert, Localisation of Adenosine Receptors in Brain and Periphery. -- J. Shimada and F. Suzuki, Medicinal Chemistry of Adenosine Receptors in Brain and Periphery. -- A. Karasawa, Overview of the Physiology and Pharmacology of Adenosine in the Peripheral System. -- H. Nonaka and M. Ichimura, Biochemical Characterizatoin of Adenosine Agonists and Antagonists. -- A. Mori and T. Shindou, Physiology of Adenosine Receptors in the Striatum: Regulation of Striatal Projection Neurons. -- P. Richardson and M. Kurokawa, The Regulation of Neurotransmitter Release in Basal Ganglia by Adenosine Receptor Agonists and Antagonists in Vitro and in Vivo. -- A. Dixon and P. Richardson, Control of Gene Expression in the Basal Ganglia Induced by Adenosine Receptors. -- S. Aoyama, J.-H. Baik, H. Kase, and E. Borrelli, Knockout Mice in the Study of Dopaminergic Diseases. -- S. Shiozaki, S. Ichikawa, J. Nakamura, and Y. Kuwana, Effects of Adenosine Receptors Experimental Models of Cognition and Motor Behaviour. -- T. Kanda and P. Jenner, Actions of Adenosine Antagonists in a Primate Model of Parkinson's Disease. -- A. Tahar, R. Grondin, L. Gregoire, A. Mori, H. Kase, and P.J. Bedard, Selective Adenosine A2A Receptor Antagonism as an Alternative Therapy for Parkinson's Disease: A Study in Nonhuman Primates. -- M. Nomoto, Neurobiology of Adenosine Receptors: Adenosine and its Metabolites in Movement Disorders.

This book is the first definitive overview on adenosine receptor antagonists and their application to the treatment of Parkinson's Disease. The effect of these novel non-dopamine drugs on vitro and in vivo systems clearly shows their potential for the treatment of this debilitating disease. This book covers how the Parkinson's disease antagonist drug, A2A, has been researched, developed, and tested. It is an essential book for researchers interested in the basal ganglia, purine biology, and Parkinson's Disease. Key Features * Discusses the discovery and development of a novel non-dopaminomimetic agent for Parkinson's disease * Provides the first definitive overview of adenosine antagonists and their role in the treatment of Parkinson's disease * Presents a new mechanism of action of adenosine A2A receptor antagonists in motor function Proposes a hypothesis of adenosine A2A receptor function in the striatum * Comprehensive overview of adenosine, its receptor subtypes, their antagonists/agonists from biochemistry, molecular biology, medicinal chemistry, physiology, pharmacology, and neurochemistry viewpoints.

Electronic reproduction.
Amsterdam :
Elsevier Science & Technology,
2007.

Mode of access: World Wide Web.

ISBN: 9780124004054

Source: 79258:79258Elsevier Science & Technologyhttp://www.sciencedirect.comSubjects--Topical Terms:

302415
Parkinson's disease.
Index Terms--Genre/Form:

214472
Electronic books.

LC Class. No.: RC382 / .A34 2000eb

Dewey Class. No.: 616.8/33

National Library of Medicine Call No.: 2000 A-764

Adenosine receptors and Parkinson's disease
LDR:04308cmm 2200373Ia 4500 001 288285
003 OCoLC
005 20110614113935.0
006 m d
007 cr cn|||||||||
008 110628s2000 cauaf ob 001 0 eng d
020 $a 9780124004054
020 $a 0124004059
029 1 $a NZ1 $b 12433376
029 1 $a AU@ $b 000042525355
035 $a (OCoLC)162574424
035 $a ocn162574424
037 $a 79258:79258 $b Elsevier Science & Technology $n http://www.sciencedirect.com
040 $a OPELS $b eng $c OPELS $d OCLCG $d OCLCQ
049 $a TEFA
050 1 4 $a RC382 $b .A34 2000eb
060 1 4 $a 2000 A-764
060 1 4 $a WL 359 $b A232a 2000
082 0 4 $a 616.8/33 $2 22
245 0 0 $a Adenosine receptors and Parkinson's disease $h [electronic resource] / $c edited by Hiroshi Kase, Peter J. Richardson, Peter Jenner.
260 $a San Diego, CA : $b Academic Press, $c c2000.
300 $a xviii, 275 p. [1] col. plate : $b ill. ; $c 24 cm.
490 1 $a Pure and applied mathematics series ; $v v. 90
504 $a Includes bibliographical references and index.
505 0 $a H. Kase, Introductory Remarks: Adenosine A2A Receptor Antagonists: A Novel Approach to the Treatment of Parkinson's Disease. -- S.J. Augood, P.C. Emsom, and D.G. Standaert, Localisation of Adenosine Receptors in Brain and Periphery. -- J. Shimada and F. Suzuki, Medicinal Chemistry of Adenosine Receptors in Brain and Periphery. -- A. Karasawa, Overview of the Physiology and Pharmacology of Adenosine in the Peripheral System. -- H. Nonaka and M. Ichimura, Biochemical Characterizatoin of Adenosine Agonists and Antagonists. -- A. Mori and T. Shindou, Physiology of Adenosine Receptors in the Striatum: Regulation of Striatal Projection Neurons. -- P. Richardson and M. Kurokawa, The Regulation of Neurotransmitter Release in Basal Ganglia by Adenosine Receptor Agonists and Antagonists in Vitro and in Vivo. -- A. Dixon and P. Richardson, Control of Gene Expression in the Basal Ganglia Induced by Adenosine Receptors. -- S. Aoyama, J.-H. Baik, H. Kase, and E. Borrelli, Knockout Mice in the Study of Dopaminergic Diseases. -- S. Shiozaki, S. Ichikawa, J. Nakamura, and Y. Kuwana, Effects of Adenosine Receptors Experimental Models of Cognition and Motor Behaviour. -- T. Kanda and P. Jenner, Actions of Adenosine Antagonists in a Primate Model of Parkinson's Disease. -- A. Tahar, R. Grondin, L. Gregoire, A. Mori, H. Kase, and P.J. Bedard, Selective Adenosine A2A Receptor Antagonism as an Alternative Therapy for Parkinson's Disease: A Study in Nonhuman Primates. -- M. Nomoto, Neurobiology of Adenosine Receptors: Adenosine and its Metabolites in Movement Disorders.
520 $a This book is the first definitive overview on adenosine receptor antagonists and their application to the treatment of Parkinson's Disease. The effect of these novel non-dopamine drugs on vitro and in vivo systems clearly shows their potential for the treatment of this debilitating disease. This book covers how the Parkinson's disease antagonist drug, A2A, has been researched, developed, and tested. It is an essential book for researchers interested in the basal ganglia, purine biology, and Parkinson's Disease. Key Features * Discusses the discovery and development of a novel non-dopaminomimetic agent for Parkinson's disease * Provides the first definitive overview of adenosine antagonists and their role in the treatment of Parkinson's disease * Presents a new mechanism of action of adenosine A2A receptor antagonists in motor function Proposes a hypothesis of adenosine A2A receptor function in the striatum * Comprehensive overview of adenosine, its receptor subtypes, their antagonists/agonists from biochemistry, molecular biology, medicinal chemistry, physiology, pharmacology, and neurochemistry viewpoints.
533 $a Electronic reproduction. $b Amsterdam : $c Elsevier Science & Technology, $d 2007. $n Mode of access: World Wide Web. $n System requirements: Web browser. $n Title from title screen (viewed on Aug. 2, 2007). $n Access may be restricted to users at subscribing institutions.
650 0 $a Parkinson's disease. $3 302415
650 0 $a Adenosine $x Receptors. $3 302904
650 0 $a Adenosine $x Antagonists $x Therapeutic use. $3 502404
650 1 2 $a Parkinson Disease $x drug therapy. $3 502405
650 2 2 $a Receptors, Purinergic P1 $x antagonists & inhibitors. $3 502406
650 4 $a Adenosine. $3 502407
650 4 $a Parkinson's disease $x Treatment. $3 502408
655 4 $a Electronic books. $2 local. $3 214472
700 1 $a Kase, Hiroshi. $3 502401
700 1 $a Richardson, Peter J. $3 502402
700 1 $a Jenner, Peter, $d 1946- $3 502403
710 2 $a ScienceDirect (Online service) $3 307425
776 1 $c Original $z 0124004059 $z 9780124004054 $w (DLC) 99062783 $w (OCoLC)42214737
830 0 $a Pure and applied mathematics (Academic Press) ; $v 140. $3 441190
856 4 0 $3 ScienceDirect $u http://www.sciencedirect.com/science/book/9780124004054 $z An electronic book accessible through the World Wide Web; click for information
994 $a C0 $b TEF